(FC) Bioquímica y Genética
Departamento académico
Oscar
Briz Sánchez
Publicaciones en las que colabora con Oscar Briz Sánchez (12)
2024
-
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
Biomedicine and Pharmacotherapy, Vol. 180
2021
-
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
Hepatology, Vol. 73, Núm. 1, pp. 186-203
2020
-
MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression
Hepatology, Vol. 72, Núm. 3, pp. 949-964
2019
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2018
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485
2017
-
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma
Journal of Hepatology, Vol. 67, Núm. 1, pp. 72-83
2016
-
Bile acids in physiology, pathology and pharmacology
Current Drug Metabolism, Vol. 17, Núm. 1, pp. 4-29
-
Mechanisms of resistance to chemotherapy in gastric cancer
Anti-Cancer Agents in Medicinal Chemistry, Vol. 16, Núm. 3, pp. 318-334
2015
-
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)
Journal of Controlled Release, Vol. 216, pp. 93-102
2014
-
Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development
Molecular Cancer Research, Vol. 12, Núm. 1, pp. 91-100
2013
-
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
Hepatology, Vol. 58, Núm. 3, pp. 1065-1073